The vaccines are also easier to make and multivalent shots can be formulated in prefilled syringes, said Vicebio chief executive Emmanuel Hanon, who was formerly GSK's vaccine chief. New Cambridge ...

GSK PLC closed 21.47% short of its 52-week high of £18.24, which the company reached on May 16th.

British drugmaker GSK said on Wednesday it was "well positioned" to respond to any potential financial impact from ...

An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung cancer ...

Going forward, PTS and Appspace are providing ongoing service and support, with a team ensuring the systems perform at peak ...

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

GSK said HS-20093 has already shown activity against small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), and sarcoma in the phase 1 ARTEMIS-001 trial presented at this year’s ASCO ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best undervalued UK ...